发明名称 1,3,8-TRIAZASPIRO[4.5]DECANONE COMPOUND AS ORL1-RECEPTOR AGONIST
摘要 PROBLEM TO BE SOLVED: To obtain a new 1,3,8-triazaspiro[4.5]decanone compound useful as a painkiller, an antiflammatory agent, a diuretic, an anesthetic, a nerve- protective agent, an agent against arterial blood pressure disorder, an anxiolytic, an anorexing agent or a regulating agent for audibility. SOLUTION: This new compound is expressed by formula I [wherein, R1 and R2 are each a 1-4C alkyl or the like; A is a 1-7C alkyl, a 2-5C alkenyl or the like; R is H, a (substituted) 1-6C alkyl, a (substituted) 2-6C alkynyl, or the like; X is (substituted) phenyl, a (substituted) heterocycle or the like] and is, e.g. 3-(3-aminopropyl)-1-phenyl-8-(1-phenylcycloheptyl)-1,3,8- triazaspiro[4.5]decan-4-one. The compound of formula I is obtained, e.g. by Strecker synthesis reaction of a 1,3,8-triazaspiro[4.5]decanone of formula II with a ketone of formula III to form a compound of formula IV and then by subjecting the compound of formula IV to Grignard reaction with a reagent of the formula: AMgX' (wherein, X' is a halogen or the like).
申请公布号 JP2000128879(A) 申请公布日期 2000.05.09
申请号 JP19990296211 申请日期 1999.10.19
申请人 PFIZER PHARMACEUTICALS INC 发明人 ITO FUMITAKA;OHASHI YORIKO
分类号 C07D471/10;A61K31/435;A61K31/438;A61K31/445;A61K31/495;A61K31/535;A61K31/54;A61K31/55;A61P3/04;A61P7/10;A61P9/12;A61P23/00;A61P25/00;A61P25/04;A61P25/22;A61P29/00;A61P43/00;C07D221/00;C07D235/00;C07D401/04;(IPC1-7):C07D471/10 主分类号 C07D471/10
代理机构 代理人
主权项
地址